TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $21,000 | -73.8% | 94,274 | +23.0% | 0.00% | – |
| Q1 2018 | $80,000 | +400.0% | 76,643 | +542.0% | 0.00% | – |
| Q4 2017 | $16,000 | -15.8% | 11,939 | +12.5% | 0.00% | – |
| Q3 2017 | $19,000 | -78.9% | 10,608 | -77.6% | 0.00% | – |
| Q2 2017 | $90,000 | -59.8% | 47,311 | -30.3% | 0.00% | – |
| Q1 2017 | $224,000 | -52.6% | 67,900 | -42.6% | 0.00% | – |
| Q4 2016 | $473,000 | -37.1% | 118,263 | -7.6% | 0.00% | – |
| Q3 2016 | $752,000 | -29.4% | 128,000 | -34.3% | 0.00% | – |
| Q2 2016 | $1,065,000 | +162.3% | 194,800 | +129.7% | 0.00% | – |
| Q1 2016 | $406,000 | – | 84,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMPSON DAVIS & CO., INC. | 16,184 | $95,000 | 0.17% |
| Acrospire Investment Management LLC | 30,847 | $181,000 | 0.12% |
| Spark Investment Management LLC | 24,000 | $141,000 | 0.01% |
| ACCURATE INVESTMENT SOLUTIONS, INC. | 2,000 | $12,000 | 0.01% |
| Blume Capital Management, Inc. | 2,546 | $15,000 | 0.01% |
| BLUESTEIN R H & CO LLC | 20,000 | $118,000 | 0.01% |
| Virtu KCG Holdings LLC | 42,562 | $250,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $11,000 | 0.00% |
| Integrated Wealth Management | 910 | $5,000 | 0.00% |
| Krilogy Financial LLC | 800 | $5,000 | 0.00% |